Fingerprint
Dive into the research topics of 'Cardiovascular and renal benefits of dapagliflozin in patients with short and long-standing type 2 diabetes: Analysis from the DECLARE-TIMI 58 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically